208 related articles for article (PubMed ID: 11733869)
1. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Horm Metab Res; 2001 Nov; 33(11):664-9. PubMed ID: 11733869
[TBL] [Abstract][Full Text] [Related]
2. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610
[TBL] [Abstract][Full Text] [Related]
3. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
4. Role of TGF-beta/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model.
Ricci C; Iacobini C; Oddi G; Amadio L; Menini S; Rastaldi MP; Frasheri A; Pricci F; Pugliese F; Pugliese G
Nephrol Dial Transplant; 2006 Jun; 21(6):1514-24. PubMed ID: 16449286
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
Russo LM; del Re E; Brown D; Lin HY
Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
[TBL] [Abstract][Full Text] [Related]
6. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats.
Zhang YW; Xie D; Xia B; Zhen RT; Liu IM; Cheng JT
Horm Metab Res; 2006 Feb; 38(2):82-8. PubMed ID: 16523407
[TBL] [Abstract][Full Text] [Related]
7. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
9. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.
Fernandes R; Carvalho AL; Kumagai A; Seica R; Hosoya K; Terasaki T; Murta J; Pereira P; Faro C
Mol Vis; 2004 Aug; 10():618-28. PubMed ID: 15359219
[TBL] [Abstract][Full Text] [Related]
11. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
12. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
13. Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats.
Paczek L; Gaciong Z; Bartlomiejczyk I; Sebekova K; Birkenmeier G; Heidland A
Drugs Exp Clin Res; 2001; 27(4):141-9. PubMed ID: 11822224
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary TGF-beta1 and cortical renal GLUT1 and GLUT2 levels: additive effects of hypertension and diabetes.
Schaan BD; Irigoyen MC; Bertoluci MC; Lima NG; Passaglia J; Hermes E; Oliveira FR; Okamoto M; Machado UF
Nephron Physiol; 2005; 100(3):p43-50. PubMed ID: 15855808
[TBL] [Abstract][Full Text] [Related]
15. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy.
Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R
Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017
[TBL] [Abstract][Full Text] [Related]
17. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
18. Sympathetic modulation of the renal glucose transporter GLUT2 in diabetic rats.
Schaan BD; Irigoyen MC; Lacchini S; Moreira ED; Schmid H; Machado UF
Auton Neurosci; 2005 Jan; 117(1):54-61. PubMed ID: 15620570
[TBL] [Abstract][Full Text] [Related]
19. [Regulation of the expression and function of glucose transporter-1 by TGF-beta 1 and high glucose in mesangial cells].
Zhang J; Liu Z; Liu H; Li Y; Li L
Chin Med J (Engl); 2000 Jun; 113(6):508-13. PubMed ID: 11775867
[TBL] [Abstract][Full Text] [Related]
20. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
